These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20502862)

  • 21. A cohort study of incident microalbuminuria in relation to HOMA-IR in Korean men.
    Park SK; Chun H; Ryoo JH; Lee SW; Lee HS; Shim KW; Cho CY; Ryu DR; Ko TS; Kim E; Park SJ; Park JH; Hong SJ; Hong HP
    Clin Chim Acta; 2015 Jun; 446():111-6. PubMed ID: 25896961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of serum ferritin level as an independent predictor of insulin resistance in Korean men.
    Park SK; Choi WJ; Oh CM; Kim MG; Ham WT; Choi JM; Ryoo JH
    Diabetes Res Clin Pract; 2015 Jan; 107(1):187-93. PubMed ID: 25438938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study.
    Wang T; Li M; Zeng T; Hu R; Xu Y; Xu M; Zhao Z; Chen Y; Wang S; Lin H; Yu X; Chen G; Su Q; Mu Y; Chen L; Tang X; Yan L; Qin G; Wan Q; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Deng H; Zhao J; Shi L; Ning G; Bi Y; Wang W; Lu J
    Diabetes Care; 2022 Aug; 45(8):1863-1872. PubMed ID: 35700159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance and fasting hyperinsulinemia are risk factors for new cardiovascular events in patients with prior coronary artery disease and normal glucose tolerance.
    Yanase M; Takatsu F; Tagawa T; Kato T; Arai K; Koyasu M; Horibe H; Nomoto S; Takemoto K; Shimizu S; Watarai M
    Circ J; 2004 Jan; 68(1):47-52. PubMed ID: 14695465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study.
    Resnick HE; Jones K; Ruotolo G; Jain AK; Henderson J; Lu W; Howard BV;
    Diabetes Care; 2003 Mar; 26(3):861-7. PubMed ID: 12610050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort study.
    Schrauben SJ; Jepson C; Hsu JY; Wilson FP; Zhang X; Lash JP; Robinson BM; Townsend RR; Chen J; Fogelfeld L; Kao P; Landis JR; Rader DJ; Hamm LL; Anderson AH; Feldman HI
    BMC Nephrol; 2019 Feb; 20(1):60. PubMed ID: 30786864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Ferritin, Insulin Resistance, and β-cell Dysfunction: A Prospective Study in Normoglycemic Japanese Men.
    Nakamura K; Sakurai M; Morikawa Y; Nagasawa SY; Miura K; Ishizaki M; Kido T; Naruse Y; Nakashima M; Nogawa K; Suwazono Y; Nakagawa H
    Exp Clin Endocrinol Diabetes; 2017 Jan; 125(1):12-20. PubMed ID: 27750351
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical association between serum γ-glutamyltransferase levels and the development of insulin resistance in Korean men: a 5-year follow-up study.
    Ryoo JH; Oh CM; Kim HS; Park SK; Choi JM
    Diabet Med; 2014 Apr; 31(4):455-61. PubMed ID: 24102943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance and the development of cardiovascular disease in a Japanese community: the Hisayama study.
    Gotoh S; Doi Y; Hata J; Ninomiya T; Mukai N; Fukuhara M; Kamouchi M; Kitazono T; Kiyohara Y
    J Atheroscler Thromb; 2012; 19(11):977-85. PubMed ID: 22814404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
    Fragoso A; Mendes F; Silva AP; Neves PL
    J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin resistance and acute coronary syndrome.
    Caccamo G; Bonura F; Bonura F; Vitale G; Novo G; Evola S; Evola G; Grisanti MR; Novo S
    Atherosclerosis; 2010 Aug; 211(2):672-5. PubMed ID: 20466373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fasting insulin, insulin resistance, and risk of cardiovascular or all-cause mortality in non-diabetic adults: a meta-analysis.
    Zhang X; Li J; Zheng S; Luo Q; Zhou C; Wang C
    Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28811358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SPISE and other fasting indexes of insulin resistance: risks of coronary heart disease or type 2 diabetes. Comparative cross-sectional and longitudinal aspects.
    Cederholm J; Zethelius B
    Ups J Med Sci; 2019 Nov; 124(4):265-272. PubMed ID: 31694444
    [No Abstract]   [Full Text] [Related]  

  • 34. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease.
    Shinohara K; Shoji T; Emoto M; Tahara H; Koyama H; Ishimura E; Miki T; Tabata T; Nishizawa Y
    J Am Soc Nephrol; 2002 Jul; 13(7):1894-900. PubMed ID: 12089386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance negatively affects long-term outcome in non-diabetic patients with coronary artery disease after therapies to reduce atherosclerotic risk factors.
    Kitta Y; Nakamura T; Uematsu M; Sugamata W; Deyama J; Fujioka D; Saito Y; Kawabata K; Obata JE; Kugiyama K
    J Cardiol; 2013 Dec; 62(6):348-53. PubMed ID: 23810069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fasting hyperinsulinaemia and 2-h glycaemia predict coronary heart disease in patients with type 2 diabetes.
    Faghihi-Kashani S; Bonnet F; Hafezi-Nejad N; Heidari B; Aghajani Nargesi A; Sheikhbahaei S; Ebadi M; Esteghamati A
    Diabetes Metab; 2016 Feb; 42(1):55-61. PubMed ID: 26531321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.
    Jeppesen J; Hansen TW; Olsen MH; Rasmussen S; Ibsen H; Torp-Pedersen C; Hildebrandt PR; Madsbad S
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):594-8. PubMed ID: 18753952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study.
    Ghasemi A; Tohidi M; Derakhshan A; Hasheminia M; Azizi F; Hadaegh F
    Acta Diabetol; 2015 Oct; 52(5):905-15. PubMed ID: 25794879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of HOMA-IR, HOMA-β% and disposition index between US white men and Japanese men in Japan: the ERA JUMP study.
    Ahuja V; Kadowaki T; Evans RW; Kadota A; Okamura T; El Khoudary SR; Fujiyoshi A; Barinas-Mitchell EJ; Hisamatsu T; Vishnu A; Miura K; Maegawa H; El-Saed A; Kashiwagi A; Kuller LH; Ueshima H; Sekikawa A;
    Diabetologia; 2015 Feb; 58(2):265-71. PubMed ID: 25316435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HOMA-estimated insulin resistance is associated with hypertension in Iranian diabetic and non-diabetic subjects.
    Esteghamati A; Khalilzadeh O; Abbasi M; Nakhjavani M; Novin L; Esteghamati AR
    Clin Exp Hypertens; 2008 Jul; 30(5):297-307. PubMed ID: 18633753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.